Abstract
Antinociceptive profiles of curcumin in ICR mice were examined. Curcumin administered orally (from 1 to 10 mg/kg) showed an antinociceptive effect in a dose-dependent manner as measured in the acetic acid-induced writhing test. Duration of antinociceptive action of curcumin was maintained at least for 60 min. Moreover, cumulative response time of nociceptive behaviors induced with intraplantar formalin injection was reduced by curcumin treatment during second phase. Cumulative nociceptive response time for intrathecal injection of substance P (0.7 μg) or glutamate (20 μg) was diminished by curcumin. Intraperitoneal pretreatment with naloxone (opioid receptor antagonist) or methysergide (5-HT serotonergic receptor antagonist)-attenuated antinociceptive effect induced by curcumin in the writhing test, whereas yohimbine (α2-adrenergic receptor antagonist) did not affect antinociception induced by curcumin, suggesting that curcumin shows antinociceptive property in various pain models, and this antinociceptive effect of curcumin may be mediated by opioidergic and serotonergic receptors, but not α2-adrenergic receptor.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Korean Society for Applied Biological Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
